Colterol
Chemical compound
Clinical data | |
---|---|
Other names | N-tert-Butylarterenol; N-tert-Butylnoradrenaline |
Identifiers | |
| |
CAS Number |
|
PubChem CID |
|
ChemSpider |
|
UNII |
|
CompTox Dashboard (EPA) |
|
Chemical and physical data | |
Formula | C12H19NO3 |
Molar mass | 225.288 g·mol−1 |
3D model (JSmol) |
|
| |
InChI
|
Colterol is a short-acting β2-adrenoreceptor agonist. Bitolterol, a prodrug for colterol,[1] is used in the management of bronchospasm in asthma and chronic obstructive pulmonary disease (COPD).
References
- ^ Walker SB, Kradjan WA, Bierman CW (6 May 1985). "Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma". Pharmacotherapy. 5 (3): 127–37. doi:10.1002/j.1875-9114.1985.tb03410.x. PMID 3895171. S2CID 29431526.
- ^ Aktiengesellschaft F Hoffmann, CH263801 (1949-09-15 to Hoffmann La Roche).
- ^ Yasuo Konishi, Joanne Magoon, Suwatchai Jarussophon, WO2008092257 (2008 to National Research Council Of Canada). Location in patent: Page column 17.
- v
- t
- e
Adrenergic receptor modulators
- See also: Receptor/signaling modulators
- Dopaminergics
- Serotonergics
- Monoamine reuptake inhibitors
- Monoamine releasing agents
- Monoamine metabolism modulators
- Monoamine neurotoxins
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e